Sign In

Nagham Nafiz Hendi

Personal Information

Dr. Nagham Nafiz Hendi

Faculty member

Dr. Nagham Nafiz Hendi is an Assistant Professor of Biomedical Sciences and Genomics at the Faculty of Pharmacy, Applied Science University. She obtained her Ph.D. in Biomedical and Biological Sciences (2019–2023) from Hamad Bin Khalifa University (Qatar Foundation), graduating first in her class with distinction and receiving a fully funded scholarship. Her doctoral research contributed to the first genome-wide association studies on vitamin D deficiency in Middle Eastern populations and the functional characterization of the novel SDR42E1 gene. She also holds an M.Sc. in Clinical Pharmacy (2017) from the University of Jordan and a B.Sc. in Pharmacy (2015), with excellent standing.

Dr. Hendi previously served as an Assistant Professor at Middle East University (2024), a Postdoctoral Researcher in Bioinformatics and Translational Biomedicine at Hamad Bin Khalifa University and Sidra Medicine (2023–2024) in Qatar, and earlier as a Lecturer at the University of Jordan (2017–2019). She is the recipient of the Paul Dudley White International Scholar Award (2024) and the Academic Research Grant (2025) from Qatar Research, Development and Innovation (QRDI). Dr. Hendi has numerous publications in high-impact journals and conferences and is an active member of the American and European Societies of Human Genetics, contributing to international collaborations in genomics and precision medicine.​

  • Dr. Hendi’s research focuses on integrating genomics and translational biomedicine to elucidate the genetic and molecular mechanisms underlying complex diseases. She employs bioinformatics, pharmacogenomics, and multi-omics approaches—including genomics, transcriptomics, and epigenomics—to identify biomarkers and therapeutic targets that advance precision medicine. Her work also investigates genetic diversity and population structuring in Middle Eastern and global cohorts, applying computational and machine-learning methods to enhance disease prediction and personalized therapeutics.​